![Heico Breek](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Heico Breek
Directeur Général chez ACS Biomarker BV
Provenance du réseau au premier degré de Heico Breek
Entité | Type d'entité | Industrie | |
---|---|---|---|
ACS Biomarker BV
![]() ACS Biomarker BV Medical SpecialtiesHealth Technology ACS Biomarker BV develops and commercializes cardiovascular biomarkers. The firm offers miRNA profiling services. It engages in the discovery, validation, and commercialization of biomarkers that improve diagnosis, prognosis and management of cardiac diseases. The company was founded in 2007 by Mat J. A. P. Daemen, Yigal M. Pinto and Tilman Hackeng and is headquartered in Maastricht, the Netherlands.
5
| Holding Company | Medical Specialties | 5 |
Encapson BV
![]() Encapson BV Miscellaneous Commercial ServicesCommercial Services Encapson BV operates as a medical device technology company. It specializes in the use of polymer-based capsules for microencapsulation. The company's products include Capsol, a paclitaxol delivery method for drug eluting balloons; and Sono-coat, an echogenic coating that is applied for biopsy and anesthesiology needles, brachytherapy needles, guiding and embryo transfer catheters, and drainage catheters. Encapson was founded by Lee Ayres and Dennis Manuel Vriezema in 2005 and is headquartered in Enschede, the Netherlands.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Holding Company | Medical Specialties | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Heico Breek via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
FOOT LOCKER, INC. | Apparel/Footwear Retail | Corporate Officer/Principal | |
Academic Medical Center
![]() Academic Medical Center Hospital/Nursing ManagementHealth Services Academic Medical Center operates a medical center and a medical research facility. It also provides education and training. The company was founded in 1983 and is headquartered in Amsterdam, the Netherlands. | Hospital/Nursing Management | Corporate Officer/Principal | |
AGFA-GEVAERT NV | Electronics/Appliances | Director/Board Member | |
LSP Management Group BV
![]() LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Investment Managers | Director of Finance/CFO | |
Maastricht University | College/University | Corporate Officer/Principal | |
The Scripps Research Institute
![]() The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal | |
Smeets Securities BV | Corporate Officer/Principal | ||
Next
![]() Next Electronics DistributorsDistribution Services Part of Arrow Electronics, Inc., Next is a Swedish company that distributes products and services for Sun Microsystems. Next was acquired by Arrow ECS Central GmbH, a SUB of Arrow Electronics, Inc. from Dimension AB on February 10, 2003. | Electronics Distributors | Corporate Officer/Principal | |
The University of York | College/University | Undergraduate Degree | |
Erasmus University Rotterdam | College/University | Graduate Degree | |
University of Utrecht | College/University | Graduate Degree | |
University of Groningen | College/University | Doctorate Degree | |
Colegio Universitario de Estudios Financieros | College/University | Masters Business Admin | |
Ghent University | College/University | Graduate Degree | |
Amonis Organisme de Financement de Pensions
![]() Amonis Organisme de Financement de Pensions Financial ConglomeratesFinance Amonis Organisme de Financement de Pensions is a pension and insurance specialist for medical and liberal professions. The private company is based in Brussels, Belgium. and has subsidiaries in Belgium. Amonis has been providing guidance to self-employed individuals and salaried employees for over 50 years. The CEO of the Belgian company is Françoise Leclercq. | Financial Conglomerates | Director/Board Member | |
Forbion Capital Partners Management Holding BV
![]() Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Consultant / Advisor | |
DSM Venturing BV
![]() DSM Venturing BV Investment ManagersFinance DSM Venturing BV (DSM Venturing) is the venture capital arm of Royal DSM NV in the Netherlands founded in 2001. DSM Venturing BV is headquartered in Geleen. | Investment Managers | Private Equity Investor | |
Volvo Information Technology AB
![]() Volvo Information Technology AB Information Technology ServicesTechnology Services Volvo Information Technology AB engages in the provision information technology solutions for product development and manufacturing, sales, administration, and operations and infrastructure of the Volvo Group. Its clients include the Volvo Group, Geely-owned Volvo Cars, and other industrial external companies. The company was founded in 1966 and is headquartered in Göteborg, Sweden. | Information Technology Services | Corporate Officer/Principal | |
EUROPEAN MEDICAL SOLUTIONS | Biotechnology | Chief Executive Officer | |
Université Catholique de Louvain | College/University | Graduate Degree Graduate Degree | |
The International Society On Thrombosis & Haemostasis | President | ||
Arecor Ltd.
![]() Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
PROMETHERA Biosciences SA
![]() PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Director of Finance/CFO | |
United Telecom NV
![]() United Telecom NV Specialty TelecommunicationsCommunications United Telecom NV develops software technologies for mobile operators. It provides fixed and mobile telephony and VDSL products. The company was founded in 1990 and is headquartered in Rotselaar, Belgium. | Specialty Telecommunications | Director/Board Member | |
FABPulous BV
![]() FABPulous BV Medical SpecialtiesHealth Technology FABPulous BV develops a handheld disposable plasma separation device with embedded in vitro diagnostic test capability. It offers ultra rapid plasma preparation platform that can make a defined dilution of plasma from a small volume of whole blood in seconds and integrated lateral flow IVD platform. The company’s tests provide diagnosis and benefit to the patient, as well as the healthcare sector, the insurance industry, governments and society in general. FABPulous was founded in 2008 and is headquartered in Maastricht, the Netherlands. | Medical Specialties | Director/Board Member | |
Cristal Delivery BV
![]() Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
OncoDNA SA
![]() OncoDNA SA Medical/Nursing ServicesHealth Services OncoDNA SA develops and provides diagnostic and analytical tools for cancer treatment. The firm offers treatment options, integrated biological review, monitoring, pathology and DNA sequencing. The company was founded by Jean-Pol Detiffe on November 29, 2012 and is headquartered in Gosselies, Belgium. | Medical/Nursing Services | Chief Executive Officer | |
Brightlands Venture Partners BV
![]() Brightlands Venture Partners BV Investment ManagersFinance Brightlands Venture Partners is an independent regional venture capital firm headquartered in Brightlands, Netherlands. The firm was founded in 2004. | Investment Managers | Private Equity Investor | |
CARIM School for Cardiovascular Diseases | Director/Board Member | ||
Innovation Industries Management BV
![]() Innovation Industries Management BV Investment ManagersFinance Innovation Industries Management BV (Innovation Industries Management) is an independent venture capital firm founded in 2016. The firm is headquartered in Noord-Holland, the Netherlands. | Investment Managers | Private Equity Investor | |
Vivet Therapeutics SAS
![]() Vivet Therapeutics SAS BiotechnologyHealth Technology Vivet Therapeutics SAS develops novel gene therapy treatments for inherited metabolic diseases. The firm offers its services under the categorizers of Biopharma, Biotechnology and Health Care. The company was founded by Jean-Philippe Combal, Gloria Gonzalez-Aseguinolaza and Jens Kurth on July 26, 2016 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Citryll BV
![]() Citryll BV Miscellaneous Commercial ServicesCommercial Services Citryll BV is a private pharmaceutical company located in Oss, the Netherlands, at the Pivot Park. Citryll is dedicated to developing and commercializing therapeutics that target netosis and NETs, with a focus on immune-mediated inflammatory diseases. The Dutch company's lead antibody, Cit-013, has a unique dual mode of action and proprietary NET biomarker assays, making it a promising drug for rheumatoid arthritis and hidradenitis suppurativa. The initial clinical trials with Cit-013 are expected to provide the foundation for a new treatment paradigm for immune-mediated inflammatory diseases. The company was founded in 2015 by Helmuth van Es, Renato Chirivi, and the late Jos Raats of ModiQuest. | Miscellaneous Commercial Services | Chief Executive Officer | |
Sutura Therapeutics Ltd.
![]() Sutura Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Sutura Therapeutics Ltd. is a British biopharmaceutical company that is advancing biomolecular medicine through its Peptigo technology platform. The company is based in Macclesfield, UK. Sutura's team is made up of skilled and passionate professionals who bring a unique perspective to the table. The company was founded in 2020, and Edwin J. Wagena has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
Neuroplast BV
![]() Neuroplast BV BiotechnologyHealth Technology Neuroplast BV is a Dutch stem cell technology company that focuses on developing autologous cell products for the treatment of primarily inflammation-driven neurological disorders. Neuroplast is located in Brightlands Chemelot Campus in the Netherlands. The company's transformative treatment, Neuro-cellsò, is currently being tested for traumatic spinal cord injury (TSCI) and aims to reduce the irreversible impact of TSCI during the crucial first phase. The company was founded in August 2014 by physician De Munter and neurologist Erik Wolters, and current investors include Invest, Brightlands Venture Partners, and Liof NV. Johannes de Munter has been the CEO of the company since 2016. | Biotechnology | Director/Board Member | |
Engitix Therapeutics Ltd. | Chairman | ||
Ariceum Therapeutics GmbH
![]() Ariceum Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Ariceum Therapeutics GmbH is a German clinical stage radiopharmaceutical company that focuses on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. Ariceum Therapeutics is based in Berlin, DE, and has subsidiaries in various locations worldwide. The company's lead targeted systemic radiopharmaceutical product, -satoreotide tetraxetan ("satoreotide"), is an antagonist of the somatostatin type 2 (sstr2) receptor, which is overexpressed in neuroendocrine tumors (NETs) and some aggressive cancers such as small cell lung cancer (SCLC) and Merkel cell carcinoma. Ariceum is also developing a radiolabeled PARP-inhibitor (ATT-001), which is slated to enter the clinic in early 2024. The company was founded in 2021, and Manfred Rüdiger has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Chairman | |
Phlox Therapeutics BV
![]() Phlox Therapeutics BV BiotechnologyHealth Technology Phlox Therapeutics BV is a Dutch company that develops gene therapy to alleviate and cure cardiomyopathies. The company is based in Naarden, Netherlands. The company was founded by Yigal M. Pinto, Eva van Rooijen. | Biotechnology | Founder |
Statistiques
Internationale
Pays-Bas | 25 |
Belgique | 11 |
Royaume-Uni | 5 |
Etats-Unis | 4 |
Suède | 3 |
Sectorielle
Health Technology | 14 |
Finance | 13 |
Consumer Services | 10 |
Commercial Services | 5 |
Health Services | 3 |
Opérationnelle
Director/Board Member | 42 |
Corporate Officer/Principal | 16 |
Chairman | 14 |
Chief Executive Officer | 14 |
Founder | 10 |
Relations les plus connectées
- Bourse
- Insiders
- Heico Breek
- Connexions Sociétés